Filing Details
- Accession Number:
- 0001209191-16-124062
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-05-27 16:38:06
- Reporting Period:
- 2016-05-25
- Filing Date:
- 2016-05-27
- Accepted Time:
- 2016-05-27 16:38:06
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1077183 | Neogenomics Inc | NEO | Services-Testing Laboratories (8734) | 742897368 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1518733 | M Douglas Oort Van | 12701 Commonwealth Drive Suite 9 Fort Myers FL 33913 | Chairman And Ceo | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2016-05-25 | 600,000 | $1.71 | 2,275,000 | No | 4 | M | Direct | |
Common Stock | Disposition | 2016-05-25 | 118,613 | $8.65 | 2,156,387 | No | 4 | F | Direct | |
Common Stock | Disposition | 2016-05-26 | 98,387 | $8.69 | 2,058,000 | No | 4 | S | Direct | |
Common Stock | Disposition | 2016-05-27 | 383,000 | $8.74 | 1,675,000 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | F | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Disposition | 2016-05-25 | 600,000 | $1.71 | 600,000 | $1.71 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
200,000 | 2013-02-14 | 2017-02-14 | No | 4 | X | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 187,500 | Indirect | Conundrum Capital Partners |
Common Stock | 1,675,000 | Direct |
Reported Derivative Holdings
Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy | $7.15 | 2017-04-20 | 2021-04-20 | 472,527 | 472,527 | Direct |
Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|
2021-04-20 | 472,527 | 472,527 | Direct |
Footnotes
- Conundrum Capital Partners, LLC is a limited liability partnership 50% owned by Mr. VanOort. Mr. VanOort is a managing partner of ConundrumCapital Partners, LLC.
- Shares withheld by NeoGenomics Inc. to satisfy the cost of the shares in connection with the May 25, 2016 stock option exercise.
- Closing stock price on date of exercise, May 25, 2016.
- Includes 125,000 shares of restricted stock that the Board of Directors approved and granted on April 15, 2014. The terms of the award call for the stock to vest on the third anniversary of the grant date as long as Mr. VanOort is still an employee of the Company. This was disclosed in our Quarterly Report on Form 10-Q as filed with the Securities and Exchange Commission on July 29, 2014.
- On April 20, 2016, Mr. VanOort was granted 472,527 stock options. These options vest ratably over the first three anniversary dates of the grant date.
- On February 14, 2012, Mr. VanOort was granted options to purchase 800,000 shares. These shares vest equally over each of the first four anniversaries of the grant date. On May 25, 2016. Mr. VanOort exercised 600,000 of these options leaving a balance of 200,000 options.